FDA’s Hopes For User Fee Un-Sequestration Likely Hinge On Senate Appropriations Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
House leadership plans a comprehensive bill to undo sequestration for the government as a whole, but Rep. Robert Aderholt, who chairs the House subcommittee that originates appropriations for FDA, says he is willing to work with Senate appropriators in conference on a fix specific to the agency’s user fees.
You may also be interested in...
Hamburg Tries To “Cope” With FDA Budget, Pines For Predictability
The commissioner says FDA cannot operate effectively without predictable budgets, just as industry needs consistent FDA policy and actions for successful drug development. Making sequestered user fees available could be accomplished in fiscal 2014 budget negotiations.
FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted
Rep. Farr says Congressional Budget Office scoring problems could not be overcome, meaning FY 2013 FDA user fees lost to sequester may not be recovered, but amendment will be proposed to ensure FY 2014 fees are not lost in the upcoming appropriations bill.
FDA’s 8.2% Solution: Sequestration Would Cut $319 Million
The estimated reduction, included in the White House Office of Management and Budget’s report to Congress, is equal the cost of 900 to 1,200 agency employees, an agency advocate said.